BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34952995)

  • 21. Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
    Back AR; Schleis SE; Smrkovski OA; Lee J; Smith AN; Phillips JC
    Vet Comp Oncol; 2015 Dec; 13(4):398-408. PubMed ID: 23910023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response rate to a single dose of vinblastine administered to dogs with treatment-naive multicentric lymphoma.
    Harding K; Bergman N; Smith A; Lindley S; Szivek A; Milner R; Brawner W; Lejeune A
    Vet Comp Oncol; 2018 Dec; 16(4):636-641. PubMed ID: 30117260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.
    Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB
    J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
    London CA; Malpas PB; Wood-Follis SL; Boucher JF; Rusk AW; Rosenberg MP; Henry CJ; Mitchener KL; Klein MK; Hintermeister JG; Bergman PJ; Couto GC; Mauldin GN; Michels GM
    Clin Cancer Res; 2009 Jun; 15(11):3856-65. PubMed ID: 19470739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma.
    Boyé P; Serres F; Marescaux L; Hordeaux J; Bouchaert E; Gomes B; Tierny D
    PLoS One; 2017; 12(5):e0177486. PubMed ID: 28505195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.
    Lurie DM; Gordon IK; Théon AP; Rodriguez CO; Suter SE; Kent MS
    J Vet Intern Med; 2009; 23(5):1064-70. PubMed ID: 19627472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
    Garrett LD; Thamm DH; Chun R; Dudley R; Vail DM
    J Vet Intern Med; 2002; 16(6):704-9. PubMed ID: 12465768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma.
    Jeffreys AB; Knapp DW; Carlton WW; Thomas RM; Bonney PL; Degortari A; Lucroy MD
    J Am Anim Hosp Assoc; 2005; 41(4):221-6. PubMed ID: 15995158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine.
    Van Vechten M; Helfand SC; Jeglum KA
    J Vet Intern Med; 1990; 4(4):187-91. PubMed ID: 2401965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.
    Michels GM; Walsh KF; Kryda KA; Mahabir SP; Walters RR; Hoevers JD; Martinon OM
    Vet Dermatol; 2016 Dec; 27(6):505-e136. PubMed ID: 27647513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Response and Adverse Event Profile of Bleomycin Chemotherapy for Canine Multicentric Lymphoma.
    Smith AA; Lejeune A; Kow K; Milner RJ; Souza CH
    J Am Anim Hosp Assoc; 2017; 53(2):128-134. PubMed ID: 27841682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of the effect of prednisone omission from a multidrug chemotherapy protocol on treatment outcome in dogs with peripheral nodal lymphomas.
    Childress MO; Ramos-Vara JA; Ruple A
    J Am Vet Med Assoc; 2016 Nov; 249(9):1067-1078. PubMed ID: 27767437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results.
    Zandvliet M; Rutteman GR; Teske E
    Vet J; 2013 Sep; 197(3):656-61. PubMed ID: 23746872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).
    Rassnick KM; Mauldin GE; Al-Sarraf R; Mauldin GN; Moore AS; Mooney SC
    J Vet Intern Med; 2002; 16(5):576-80. PubMed ID: 12322709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of Bleomycin and Cytosine Arabinoside Chemotherapy for Relapsed Canine Lymphoma.
    Batschinski K; Dervisis N; Kitchell B; Newman R; Erfourth T
    J Am Anim Hosp Assoc; 2018; 54(3):150-155. PubMed ID: 29558212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.
    Davies O; Szladovits B; Polton G; Garden OA; Leo C; Lara-Garcia A
    Vet Comp Oncol; 2018 Jun; 16(2):276-287. PubMed ID: 29271043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
    Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
    Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
    Marconato L; Bonfanti U; Stefanello D; Lorenzo MR; Romanelli G; Comazzi S; Zini E
    Vet Comp Oncol; 2008 Jun; 6(2):80-9. PubMed ID: 19178667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of temozolomide or dacarbazine in combination with an anthracycline for rescue chemotherapy in dogs with lymphoma.
    Dervisis NG; Dominguez PA; Sarbu L; Newman RG; Cadile CD; Swanson CN; Kitchell BE
    J Am Vet Med Assoc; 2007 Aug; 231(4):563-9. PubMed ID: 17696856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Can Vet J; 2016 Mar; 57(3):271-6. PubMed ID: 26933263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.